APPLICATIONS PUBLISHED 3 AUGUST 2005

Compounds, compsns and methods
Cytokinetics 1558083*

Treatment for haemorrhagic shock
University of Pittsburgh of the Commonwealth System of Higher Education 1558084*

Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1558085*

Transmucosal pharmaceutical dosage form
LTS Lohmann Therapie-Systeme 1558209*

Oral extended release tablets and methods of making and using the same
Pharmacia 1558211*

Pharmaceutical and cosmetic formulations
Degussa 1558212*

Mucoadhesive tetracycline formulations
Orapharma 1558213*

Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing the same
Hanmi Pharm 1558214*

Cross-linked polymer matrices, and methods of making and using same
Johns Hopkins University School of Medicine 1558216*

Gabapentin tablets and methods for their preparation
Ranbaxy Laboratories 1558218*

Pharmaceutical formulation of olanzapine
Krka Tovarna Zdravil 1558219*

Oral compsns for treatment of diseases
Wockhardt; Iyer, Eswawan; Saoji, Dilip; Jha, Rasendrakumar 1558220*

Dosage form that is safeguarded from abuse
Gruenenthal 1558221*

Pharmaceutical compsns containing venlafaxine
Dexal Pharma Technologies 1558222*

Dosage form having an inner core and at least two coating layers
Procter & Gamble 1558223*

Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
Krka Tovarna Zdravil 1558224*

Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anaesthetics
Baxter International 1558226*

Injectable 2,6-diisopropylphenol-containing anaesthetic compsns and methods
Centurion 1558227*

Topical administration of basic antifungal compsns to treat fungal infections of nails
Dermatrends 1558228*

Combination of a CVDK inhibitor and mitoxantrone
Cyclacel 1558229*

Spirocyclopropyl amides and acids and their therapeutic uses
Abbott Laboratories 1558230*

Treating obesity with selective androgen receptor modulators
GTX 1558232*

Treating androgen decline in ageing male (ADAM)-associated conditions with SARMS
GTX 1558233*

Painless injectable compsns containing salt of 2-arylpropionic acids
Dompe 1558234*

Methods of treatment during vascular procedures
Allergan 1558235*

Lysine mixture and apparatus and method for administering lysine
Welser, Jennifer 1558236*

Improved glycemic control for prediabetes and/or diabetes type II using cdosahexanoic acid
Mertek Biosciences 1558237*

Beta-hydroxyphenylaldylamines and their use for treating glaucoma
Virginia Commonwealth University 1558238*

Combination comprising a CDK inhibitor and cisplatin
Cyclacel 1558239*

Hypoestoxides, derivatives and agonists thereof for use in the treatment of hyperlipidaemia
Paraquest 1558240*

Pharmaceutical compsns and methods of using taxane derivatives
Bristol-Myers Squibb 1558241*

Combination comprising docetaxel and a CDK inhibitor
Cyclacel 1558242*

Tetrahydropyranyl cyclopentyl nenzylamide modulators of chemokine receptor activity
Mark 1558243*

Novel nutraceutical compsns comprising epigallocatechin gallate
DSM 1558244*

Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
Novo Nordisk 1558245*

Proline derivatives having affinity for the calcium channel alpha-2 delta subunit
Pfizer 1558246*

Benzimidazole derivatives
Merck Patent 1558247*

Derivatives of [6,7-dihydro-5H-imidazo[1,2-A]imidazole-3-sulphonyl-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
Boehringer Ingelheim 1558248*

Use of Tacrolimus (FK506) derivatives combined with beta-2 agonists for the treatment of asthma
Fujisawa Pharmaceuticals 1558249*

Gamma-aminoamide modulators of chemokine receptor activity
Merck 1558250*

Method of treatment of psychological conditions by administration of nerve growth factor
Milkhaus Laboratory 1558251*

Substituted furo 2,3-B] pyridine derivatives
Merck 1558252*

Piperidinyl-alpha-aminoamide modulators of chemokine activity
Merck 1558253*

A process for preparing pharmaceutical compsns containing 4-aminoquinoline compounds for treatment of inflammatory disorders of the eye, compsns resulting therefrom
Raut, Rajeev 1558254*

Dual binding site acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Neuropharma 1558255*

Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
CLF Medical Technology Acceleration Program 1558256*

Use of piperazine sulphonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, Alzheimer's disease and other disorders
Pfizer 1558258*

IL-8 receptor antagonists
SmithKline Beecham 1558259*